Sofosbuvir/Velpatasvir for 12 Weeks in Genotype 1-4 HCV-Infected Liver Transplant Recipients

被引：0

作者：

Agarwal, Kosh ^{[1
]}

Castells, Lluis ^{[2
]}

Mullhaupt, Beat ^{[3
]}

Rosenberg, William M. ^{[4
]}

McNabb, Brian L. ^{[5
]}

Arterburn, Sarah ^{[6
]}

Camus, Gregory ^{[7
]}

McNally, John ^{[5
]}

Brainard, Diana M. ^{[5
]}

Subramanian, Mani ^{[5
]}

Gonsalkorala, Enoka ^{[1
]}

Londono, Maria ^{[8
,9
]}

Dufour, Jean-Francois ^{[10
]}

Forns, Xavier ^{[8
,9
]}

机构：

[1] Kings Coll Hosp NHS Trust Fdn, London, England

[2] Hosp Univ Val dHebron, Barcelona, Spain

[3] Univ Hosp Zurich, Zurich, Switzerland

[4] UCL, Inst Liver & Digest Hlth, London, England

[5] Gilead Sci Inc, Clin Res, 353 Lakeside Dr, Foster City, CA 94404 USA

[6] Gilead Sci Inc, Biostat, 353 Lakeside Dr, Foster City, CA 94404 USA

[7] Gilead Sci Inc, Virol, 353 Lakeside Dr, Foster City, CA 94404 USA

[8] Hosp Clin Barcelona, CIBEREHD, Barcelona, Spain

[9] IDIBAPS, Barcelona, Spain

[10] Univ Bern, Bern, Switzerland

来源：

HEPATOLOGY | 2017年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1069

引用

页码：571A / 571A

页数：1

共 50 条

[21] Sofosbuvir/GS-5816+GS-9857 for 6 or 8 Weeks in Genotype 1 or 3 HCV-infected Patients [J].

Gane, Edward J. ;

Hyland, Robert H. ;

Yang, Yin ;

Stamm, Luisa M. ;

Brainard, Diana M. ;

McHutchison, John G. ;

Stedman, Catherine A. .

HEPATOLOGY, 2015, 62 :226A-226A

[22] A Randomized Phase 3 Trial of Sofosbuvir/Velpatasvir/Voxilaprevir for 8 Weeks and Sofosbuvir/Velpatasvir for 12 Weeks for Patients with Genotype 3 HCV Infection and Cirrhosis: The POLARIS-3 Study [J].

Foster, Graham R. ;

Thompson, Alex J. ;

Ruane, Peter J. ;

Borgia, Sergio M. ;

Dore, Gregory ;

Workowski, Kimberly ;

Hyland, Robert H. ;

Wang, Jing ;

Svarovskaia, Evguenia S. ;

Stamm, Luisa M. ;

Brainard, Diana M. ;

Subramanian, Mani ;

McHutchison, John G. ;

Berg, Thomas ;

Agarwal, Kosh ;

Conway, Brian ;

Feld, Jordan J. ;

Willems, Bernard E. ;

Roberts, Stuart K. .

HEPATOLOGY, 2016, 64 :135A-136A

[23] Meta-Analysis: Sustained Virologic Response at 12 Weeks (SVR12) With Simeprevir and Sofosbuvir (SMV plus SOF) in Liver Transplant (LT) Recipients With HCV Genotype 1 (HCV-1) [J].

Nghia Nguyen ;

Yee, Brittany E. ;

Lutchman, Glen ;

Lim, Joseph K. ;

Nguyen, Mindie H. .

GASTROENTEROLOGY, 2015, 148 (04) :S1091-S1092

[24] Safety and Efficacy of Sofosbuvir/Velpatasvir in Genotype 1-6 HCV-Infected Patients in China: Results from a Phase 3 Clinical Trial [J].

Wei, Lai ;

Xie, Qing ;

Huang, Yan ;

Wu, Shanming ;

Xu, Min ;

Tang, Hong ;

Cheng, Jun ;

Gao, Yanhang ;

Mou, Zhuangbo ;

Dou, Xiaoguang ;

Nan, Yuemin ;

Ning, Qin ;

Mao, Yimin ;

Stamm, Luisa ;

Lu, Sophia ;

Dvory-Sobol, Hadas ;

Mo, Hongmei ;

Brainard, Diana ;

Yang, Yongfeng ;

Wang, Guiqiang ;

Hu, Peng ;

Zhang, Lunli ;

Gao, Zhiliang ;

Lin, Feng ;

Shang, Jia ;

Gong, Guozhong ;

Li, Jun ;

Su, Minghua ;

Duan, Zhongping ;

Hou, Jinlin ;

Jia, Jidong .

HEPATOLOGY, 2018, 68 :379A-379A

[25] Sofosbuvir/velpatasvir fixed dose combination for 12 weeks in patients co-infected with HCV and HIV-1: the phase [J].

Braeu, N. ;

Wyles, D. ;

Kottilil, S. ;

Darr, E. ;

Workowski, K. ;

Luetkemeyer, A. ;

Adeyemi, O. ;

Ruane, P. ;

Doehle, B. ;

Huang, K. C. ;

Osinusi, A. ;

McNally, J. ;

Natha, M. ;

Guion, M. ;

McLean, T. ;

Brainard, D. M. ;

McHutchison, J. G. ;

Naggie, S. ;

Sulkowski, M. .

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19

[26] A simple noninvasive index to predict fibrosis in HCV-infected liver transplant recipients [J].

Benlloch, S ;

Berenguer, M ;

Rayón, JM ;

Prieto, M ;

Aguilera, V ;

Berenguer, J .

JOURNAL OF HEPATOLOGY, 2005, 42 :45-45

[27] Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index [J].

Benlloch, S ;

Berenguer, M ;

Prieto, M ;

Rayón, JM ;

Aguilera, V ;

Berenguer, J .

LIVER TRANSPLANTATION, 2005, 11 (04) :456-462

[28] Alarming decrease in patient survival among HCV-infected liver transplant recipients [J].

Berenguer, M ;

Prieto, M ;

Aguilera, V ;

Nicolas, D ;

Carrasco, D ;

Rayon, M ;

Mir, J ;

Berenguer, J .

JOURNAL OF HEPATOLOGY, 2001, 34 :32-33

[29] SOFOSBUVIR PLUS VELPATASVIR FOR CHRONIC HCV GENOTYPE 1, 2, 3, AND 4 INFECTION [J].

Ahmed, H. ;

Attia, A. ;

Mohamed, A. ;

Elgebaly, A. ;

Negida, A. .

JOURNAL OF HEPATOLOGY, 2016, 64 :S742-S742

[30] DACLATASVIR PLUS SOFOSBUVIR FOR CHRONIC HCV-INFECTED KIDNEY TRANSPLANT RECIPIENTS - A PILOT STUDY OF EFFICACY AND SAFETY [J].

Duerr, M. ;

Staeck, O. ;

Khadzhynov, D. ;

Schrezenmeier, E. ;

Lehner, L. ;

Budde, K. ;

Halleck, F. .

TRANSPLANT INTERNATIONAL, 2016, 29 :20-20

← 1 2 3 4 5 →